Drug-resistant falciparum malaria is increasing in Africa and so methods to
map resistance on a broad scale are needed. A molecular marker for chloroq
uine resistance, pfcrt T76, can be used for surveillance of clinical chloro
quine resistance. The prevalence of pfcrt T76 and the prevalence of clinica
l chloroquine resistance and therapeutic failure were measured at sentinel
sites and used to calculate age-adjusted genotype-resistance Indices (GRIs)
and genotype-failure Indices (GFIs). We found stable GRIs and GFIs at diff
erent sites In Mail, West Africa. This model permits mapping of chloroquine
resistance using molecular tools in rapid and simple cross-sectional surve
ys.